Data / Drug companies / Guaifenesin and dextromethorphan hbr
Guaifenesin and dextromethorphan hbr: 26 companies and 51 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guaifenesin and dextromethorphan hbr is listed in the FDA National Drug Code Directory by 26 companies, with 51 products in commercial distribution. 48 of the products (94.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, and the newest product started marketing on October 27, 2026.
The request: Get every company that lists guaifenesin and dextromethorphan hbr in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 26
- Products
- 51
- Generic (ANDA) products
- 48 (94.1%)
- Application numbers
- 6
- Routes
- Oral
- Brand names
- Mucus Relief DM, Mucus Relief Cough and Congestion DM, Mucus Relief DM, Maximum Strength Mucus Relief DM, Maximum Strength Cough and Congestion Extended Release, Mucus DM, Mucus Relief DM Expectorant and Cough Suppressant Maximum Strength, Members Mark Mucus Relief DM
- openFDA record search
- api.fda.gov
Companies that list guaifenesin and dextromethorphan hbr
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aurohealth LLC | 6 | tablet, extended release | Generic drugs (ANDA) | February 24, 2021 |
| Dr. Reddy's Laboratories Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | August 15, 2023 |
| Kroger Company | 4 | tablet, extended release | Generic drugs (ANDA) | May 27, 2024 |
| CVS Woonsocket Prescription Center, Incorporated | 3 | tablet, extended release | Generic drugs (ANDA) | April 1, 2024 |
| Ahold U.S.A., Inc | 2 | tablet, extended release | Generic drugs (ANDA) | March 17, 2017 |
| Amneal Pharmaceuticals LLC | 2 | tablet, extended release | Generic drugs (ANDA) | November 1, 2018 |
| CVS Pharmacy | 2 | tablet, extended release | Generic drugs (ANDA) | March 17, 2017 |
| Harris Teeter | 2 | tablet, extended release | Generic drugs (ANDA) | August 16, 2024 |
| Ohm Laboratories Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | July 1, 2021 |
| Publix Super Markets, Inc | 2 | tablet, extended release | Generic drugs (ANDA) | July 1, 2021 |
| Safeway | 2 | tablet, extended release | Generic drugs (ANDA) | March 17, 2017 |
| Sportpharm LLC | 2 | tablet, extended release | Generic drugs (ANDA) | March 17, 2017 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | July 1, 2021 |
| Wal-Mart Stores Inc | 2 | tablet, extended release | Generic drugs (ANDA) | March 17, 2017 |
| Walgreen Company | 2 | tablet, extended release | Generic drugs (ANDA) | March 17, 2017 |
| WinCo Foods, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | March 17, 2017 |
| Advance Pharmaceutical Inc. | 1 | tablet | Over the counter monograph drugs | August 1, 2017 |
| Amazon.com Services LLC | 1 | tablet, extended release | Generic drugs (ANDA) | May 15, 2024 |
| Amerisource Bergen | 1 | tablet, extended release | Generic drugs (ANDA) | August 7, 2017 |
| Bryant Ranch Prepack | 1 | tablet | Over the counter monograph drugs | April 1, 2016 |
| Innovus Pharmaceuticals, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | October 27, 2026 |
| Richmond Pharmaceuticals, Inc. | 1 | tablet | Over the counter monograph drugs | April 1, 2016 |
| Sam's West Inc | 1 | tablet, extended release | Generic drugs (ANDA) | August 15, 2023 |
| Target Corporation | 1 | tablet, extended release | Generic drugs (ANDA) | July 4, 2024 |
| Topco Associates LLC | 1 | tablet, extended release | Generic drugs (ANDA) | April 23, 2026 |
| Vespyr Brands LLC | 1 | tablet, extended release | Generic drugs (ANDA) | July 14, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 48 | 94.1% |
| Tablet | 3 | 5.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 48 | 94.1% |
| Over the counter monograph drugs | 3 | 5.9% |
Pharmacologic classes
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.